International Clinical Trial: Evaluate the single-center, open-label, randomized, single-dose, two-period, two-sequence, crossover bioequivalence study of the test formulation Dutinoret Tablets (specification: 2 mg) and the reference formulation (URECE(R)) (specification: 2 mg) in healthy adult subjects under fasting and fed conditions

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119142) titled 'Evaluate the single-center, open-label, randomized, single-dose, two-period, two-sequence, crossover bioequivalence study of the test formulation Dutinoret Tablets (specification: 2 mg) and the reference formulation (URECE(R)) (specification: 2 mg) in healthy adult subjects under fasting and fed conditions' on Feb. 24.

Study Type: Interventional study

Study Design: Cross-over

Primary Sponsor: People's Hospital of Deyang City

Condition: Gout with hyperuricemia.

Intervention: Group B:In a fasting state, first take the test formulation (Dutasteride tablets (specification: 2 mg, manufactured by Huayi Pharmace...